ZoomInfo

DA Davidson Lowers ZoomInfo PT to $7 from $13, Maintains Neutral Rating

Citigroup

Citigroup Downgrades ZoomInfo to Sell, PT Lowered to $6.5

Barclays

Barclays Downgrades Barclays to Equal-Weight, PT Cut to $9 from $12

UBS Group

UBS Downgrades ZoomInfo to Neutral with New PT of $8.5 from $13

RBC Capital Downgrades ZoomInfo to Underperform with New PT of $7.

Catalyst<ul> <li>Fund Flow Analysis indicates a positive overall trend with inflows in Small, Large, and Extra-large order sizes suggesting potential institutional confidence in GTM.</li></ul>Risk<ul> <li>Technical indicators show a weak market state with Bearish Engulfing and multiple Long Upper Shadow signals dominating over the past five weeks, suggesting continued downward pressure.</li> <li>Analyst ratings are largely pessimistic with 3 out of 9 analysts recommending a Sell or Strong Sell, indicating significant concerns about the stock's near-term prospects.</li></ul>

Key Factors

GTM’s stock price dropped more than 10% in premarket trading following Q4 2025 earnings despite beating revenue and EPS estimates. Multiple analysts including Citigroup, RBC Capital, and Wells Fargo downgraded GTM, lowering price targets to as low as $6 and assigning underperform or sell ratings. GTM’s Q4 2025 net income rose 137.7% year-over-year, driven by AI innovation and strategic capital allocation, but its stock fell 30% month-to-date. GTM’s stock reached a 52-week low of $5.84 amid analyst downgrades and high implied volatility on options, indicating aggressive bearish positioning. GTM aims for 1% annual revenue growth in 2026 and has intensified its AI-driven upmarket strategy after reporting $319 million in Q4 revenue.

Recent Updates

GTM News